Client Result
Orrick Advises Ananda Pharma on U.S. OTCQB Listing
April.16.2025
Orrick advised Ananda Pharma plc on the admission to trading of its ordinary shares on the OTCQB Venture Market (OTCQB) in the U.S.
Client Result
FemTech Leader Willow Acquires Elvie
April.02.2025
Orrick advised Willow, the FemTech leader that revolutionized the breast pumping experience, on its acquisition of Elvie.
News
Amicus Brief Urges D.C. District Court to Protect Innovation by Rejecting Unlawful CMS Guidance on the IRA’s Drug Price Negotiation Program
March.14.2025
In a case with major implications for innovators in the biopharma industry, an Orrick team has filed an innovators' amicus brief.
Client Result
Carlyle and SK Capital to Acquire bluebird bio
March.07.2025
bluebird bio announced it will be acquired in a take private transaction by Beacon Parent Holdings, collaborating with Carlyle Group and SK Capital.
News
Eric Hochstadt Joins Orrick as Head of Antitrust Litigation
January.30.2025
We’re excited to welcome Eric Hochstadt, who has played a pivotal role in shaping modern antitrust law.
News
Orrick Welcomes the Partner Class of 2025
January.13.2025
Orrick’s 20 new partners strengthen the firm’s teams serving the tech, energy, finance and life sciences sectors.